Berkshire Hathaway Inc sold $182.9M of DaVita (DVA)

Executed May 1, disclosed May 5, 4 days later.

Value, as filed

$182.9M

1,220,376 sh × $149.84

Executed

May 1

the trade date, as filed

Disclosed

May 5

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BI Berkshire Hathaway Inc 10% owner profile →

Berkshire Hathaway Inc (10% owner) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in DaVita Inc. (DVA). The largest single filing was $212.3M of LEN (2,741,929 sh across 13 lots, as filed), executed Sep 17.

The name

DVA

DaVita Inc. DVA · Healthcare · 19 filings in 24 months ticker →

Healthcare · DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Berkshire Hathaway Inc in DVA

DVASALE DaVita Inc. $36.5M
182,980 sh × $199.55
Exec Jul 31
Filed Aug 4 · 5:27 PM ET DVASALE DaVita Inc. $54.3M
401,514 sh × $135.36
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET DVASALE DaVita Inc. $230.0M
1,635,962 sh × $140.61
Exec Jul 31 2025
Filed Aug 4 2025 · 5:30 PM ET DVASALE DaVita Inc. $168.6M
1,145,938 sh × $147.11
Exec May 8 2025
Filed May 12 2025 · 5:30 PM ET DVASALE DaVita Inc. $31.7M
203,091 sh × $156.01
Exec Feb 11 2025
Filed Feb 13 2025 · 5:30 PM ET